Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction

Asymmetrical dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthases. From a prospective cohort of patients with acute myocardial infarction (MI), we aimed to analyze the predictive value of circulating ADMA concentrations on prognosis. Blood samples from 249 co...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Arteriosclerosis, thrombosis, and vascular biology Ročník 28; číslo 5; s. 954
Hlavní autori:	Zeller, Marianne, Korandji, Claudia, Guilland, Jean-Claude, Sicard, Pierre, Vergely, Catherine, Lorgis, Luc, Beer, Jean-Claude, Duvillard, Laurence, Lagrost, Anne-Cécile, Moreau, Daniel, Gambert, Philippe, Cottin, Yves, Rochette, Luc
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.05.2008
Predmet:	Aged Aged, 80 and over Arginine - analogs & derivatives Arginine - blood Biomarkers - blood Cohort Studies Female Follow-Up Studies Humans Male Middle Aged Myocardial Infarction - blood Myocardial Infarction - mortality Predictive Value of Tests Prognosis Prospective Studies Regression Analysis
ISSN:	1524-4636, 1524-4636
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!